HCPCS code G2083 — Visit esketamine, > 56m.
Status: Active.
Effective Jan 1, 2020.
Source: CMS HCPCS Level II.
G2083
ActiveVisit esketamine, > 56m
Office or other outpatient visit for the evaluation and management of an established patient that requires the supervision of a physician or other qualified health care professional and provision of greater than 56 mg esketamine nasal self-administration, includes 2 hours post-administration observation
Category:
Procedures
Section:
G-codes: Procedures / Professional Services
Effective:
Jan 1, 2020
Code type:
alphanumeric
OPPS Status:
S
— Significant procedure — not subject to multiple procedure reduction
OPPS APC:
1518
MUE — Medically Unlikely Edits
Maximum units of G2083 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.
| Service Type | Max Units / Day |
|---|---|
| Outpatient Hospital | 1 |
| Practitioner Services | 1 |
Source: CMS Medicare NCCI Medically Unlikely Edits
Change History
Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.
-
New Code 2020-Q1Visit esketamine, > 56m